10x Genomics Statistics
Total Valuation
10x Genomics has a market cap or net worth of GBP 745.35 million. The enterprise value is 488.38 million.
Market Cap | 745.35M |
Enterprise Value | 488.38M |
Important Dates
The last earnings date was Friday, May 2, 2025.
Earnings Date | May 2, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 111.09M |
Shares Outstanding | n/a |
Shares Change (YoY) | +2.66% |
Shares Change (QoQ) | +0.83% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 109.32M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.54 |
PB Ratio | 1.36 |
P/TBV Ratio | 1.40 |
P/FCF Ratio | 21.23 |
P/OCF Ratio | 16.97 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.02 |
EV / Sales | 1.06 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 13.91 |
Financial Position
The company has a current ratio of 5.37, with a Debt / Equity ratio of 0.11.
Current Ratio | 5.37 |
Quick Ratio | 4.44 |
Debt / Equity | 0.11 |
Debt / EBITDA | n/a |
Debt / FCF | 1.77 |
Interest Coverage | -60,528.88 |
Financial Efficiency
Return on equity (ROE) is -22.03% and return on invested capital (ROIC) is -14.20%.
Return on Equity (ROE) | -22.03% |
Return on Assets (ROA) | -12.43% |
Return on Invested Capital (ROIC) | -14.20% |
Return on Capital Employed (ROCE) | -22.83% |
Revenue Per Employee | 370,201 |
Profits Per Employee | -93,066 |
Employee Count | 1,306 |
Asset Turnover | 0.68 |
Inventory Turnover | 2.50 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.70% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -66.70% |
50-Day Moving Average | 8.81 |
200-Day Moving Average | 14.68 |
Relative Strength Index (RSI) | 42.19 |
Average Volume (20 Days) | 2,751 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 4.34 |
Income Statement
In the last 12 months, 10x Genomics had revenue of GBP 483.48 million and -121.54 million in losses. Loss per share was -1.00.
Revenue | 483.48M |
Gross Profit | 330.50M |
Operating Income | -140.55M |
Pretax Income | -118.73M |
Net Income | -121.54M |
EBITDA | -113.69M |
EBIT | -140.55M |
Loss Per Share | -1.00 |
Balance Sheet
The company has 330.42 million in cash and 61.98 million in debt, giving a net cash position of 268.44 million.
Cash & Cash Equivalents | 330.42M |
Total Debt | 61.98M |
Net Cash | 268.44M |
Net Cash Per Share | n/a |
Equity (Book Value) | 547.13M |
Book Value Per Share | 4.44 |
Working Capital | 365.19M |
Cash Flow
In the last 12 months, operating cash flow was 43.92 million and capital expenditures -8.80 million, giving a free cash flow of 35.11 million.
Operating Cash Flow | 43.92M |
Capital Expenditures | -8.80M |
Free Cash Flow | 35.11M |
FCF Per Share | n/a |
Margins
Gross margin is 68.36%, with operating and profit margins of -29.07% and -25.14%.
Gross Margin | 68.36% |
Operating Margin | -29.07% |
Pretax Margin | -24.56% |
Profit Margin | -25.14% |
EBITDA Margin | -23.51% |
EBIT Margin | -29.07% |
FCF Margin | 7.26% |
Dividends & Yields
10x Genomics does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.66% |
Shareholder Yield | n/a |
Earnings Yield | -16.31% |
FCF Yield | 4.71% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
10x Genomics has an Altman Z-Score of 5.27.
Altman Z-Score | 5.27 |
Piotroski F-Score | n/a |